This site is intended for healthcare professionals
News

First patient enrolled in Sanofi’s phase III trial of SAR 442168 in relapsing multiple sclerosis.- Sanofi

Read time: 1 mins
Last updated:23th Jun 2020
Published:24th Jun 2020
Condition: Multiple Sclerosis
Type: drug
Register free for full access to medthority.com